Iqvia Holdings (IQV) Deferred Taxes (2012 - 2026)
Iqvia Holdings' (IQV) quarterly Deferred Taxes came in at -$36.0 million in Q2 2026, up 20.0% year-over-year from -$30.0 million in Q2 2025, and up 5.26% quarter-over-quarter from -$38.0 million in Q1 2026.
Analysis
Iqvia Holdings (IQV) Deferred Taxes (2012 - 2026) Analysis & Trends
Iqvia Holdings has disclosed Deferred Taxes across 15 years of filings, most recently posting -$36.0 million for Q2 2026.
- In Q2 2026, Deferred Taxes rose 20.0% year-over-year to -$36.0 million; the TTM figure through Jun 2026 stood at -$168.0 million (down 24.44% YoY), while the FY2025 annual figure was -$180.0 million, down 39.53% from the prior year.
- Deferred Taxes came in at -$36.0 million for Q2 2026 at Iqvia Holdings, up from -$38.0 million in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of -$10.0 million in Q1 2022 to a low of -$152.0 million in Q4 2023.
- Average Deferred Taxes over 5 years is -$42.6 million, with a median of -$39.5 million recorded in 2025.
- Year-over-year, Deferred Taxes sank 350.0% in 2022 and jumped 90.13% in 2024.
- Over 5 years, Deferred Taxes stood at -$63.0 million in 2022, then tumbled by 141.27% to -$152.0 million in 2023, then jumped by 90.13% to -$15.0 million in 2024, then plunged by 220.0% to -$48.0 million in 2025, then gained by 25.0% to -$36.0 million in 2026.
- Per Business Quant data, the three most recent Deferred Taxes figures were -$36.0 million in Q2 2026, -$38.0 million in Q1 2026, and -$48.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | -36.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 4.28 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | -3.28 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 41.49 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 4.90 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | - |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -36.00 Mn |
| Mar 31, 2026 | -38.00 Mn |
| Dec 31, 2025 | -48.00 Mn |
| Sep 30, 2025 | -46.00 Mn |
| Jun 30, 2025 | -45.00 Mn |
| Mar 31, 2025 | -41.00 Mn |
| Dec 31, 2024 | -15.00 Mn |
| Sep 30, 2024 | -34.00 Mn |
| Jun 30, 2024 | -14.00 Mn |
| Mar 31, 2024 | -66.00 Mn |
| Dec 31, 2023 | -152.00 Mn |
| Sep 30, 2023 | -47.00 Mn |
| Jun 30, 2023 | -43.00 Mn |
| Mar 31, 2023 | -27.00 Mn |
| Dec 31, 2022 | -63.00 Mn |
| Sep 30, 2022 | -24.00 Mn |
| Jun 30, 2022 | -18.00 Mn |
| Mar 31, 2022 | -10.00 Mn |
| Dec 31, 2021 | -55.00 Mn |
| Sep 30, 2021 | -40.00 Mn |